Platinum microcoils coated with immobilized recombinant human vascular endothelial growth factor (rhVEGF) were prepared and the effectiveness for the embolization of aneurysms was investigated using a rat model. Platinum coils were prepared by successive deposition of cationic polyethyleneimine and anionic heparin, and VEGF was immobilized through affinity interaction with heparin. Unmodified, heparin-coated, or rhVEGF-immobilized platinum coil segments were inserted into the ligated external carotid arteries at the bifurcation of the common carotid artery (CCA) of adult female rats. The bifurcation segments of the CCA were harvested 2 weeks after the coil placement. rhVEGF-immobilized coils showed significantly greater endothelial formation at the aneurysm orifice and cell infiltration in the aneurysm body compared with the unmodified and heparin-coated coils. The percentage of sac occlusion was significantly greater in the rhVEGF-immobilized group (77.53 ± 27.58%) than in the heparin-coated group (44.81 ± 38.30%) and unmodified group (34.99 ± 28.15%). Scanning electron microscopy showed a tendency for more fibrotic and cellular collections on the coil surface and more tissue mass filling in the coil lumen in the rhVEGF-immobilized group. Platinum microcoils coated with immobilized rhVEGF may be effective for the obliteration of aneurysms.
Introduction
Coil embolization therapy with the Guglielmi detachable coil (GDC) (Target Therapeutics, Fremont, Calif., U.S.A.) system is now widely used for the treatment of intracranial aneurysms. 10, 11, 18) Small aneurysms with narrow necks can be effectively treated by detachable coils. 10, 11) However, although platinum GDCs packed within a larger aneurysm can provide a framework that may be beneficial to aneurysm stability and thrombus formation, the process of clot organization appears to take longer and may remain incomplete because platinum is relatively bio-inert. Histological findings after GDC treatment of aneurysms in humans indicated that aneurysms may appear completely angiographically occluded, but unorganized clots and small fluid spaces between the coils persist with no evidence of endothelialization at the aneurysm orifice. 3, 5, 12, 17, 19, 24, 25) Clinical studies 4, 6) have shown that the recurrence rate after coil embolization therapy is as high as 14%.
Various methods to modify the coil surface have been tried to promote thrombosis, vascular cell adhesion, endothelial cell proliferation, and clot organization using extracellular matrix proteins 7, 8, 14, 21, 26, 27) (collagen, laminin, fibronectin), non-biodegradable polymers 16) (polyesters, polyurethanes), fibroblasts, 14, 15) and ion implantation. 21) Another approach used a hybrid coil made of platinum filaments and biodegradable polyglycolide fibers to enhance vascular responses compared with GDCs. 1) These approaches either promote connective tissue organization in aneurysms by stimulating fibroblast growth or enhance neointima formation at the aneurysm orifice by boosting vascular endothelial cell proliferation.
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Vascular endothelial growth factor (VEGF), a heparin-binding glycoprotein produced by various cells, such as macrophages, endothelial cells, and smooth muscle cells, stimulates vascular endothelial cell proliferation, 20, 23) and has potential therapeutic applications for enhancing collateral flow in ischemic myocardium 2) and limbs. 13) Therefore, coils carrying VEGF should enhance endothelial proliferation and subsequent neointima formation at the aneurysm orifice.
The present study developed a new method to prepare platinum coils carrying recombinant human VEGF (rhVEGF) and examined the efficacy for occluding aneurysms using a rat aneurysm model.
Materials and Methods

I. Coil preparation
Straight unmodified platinum coils of 300 mm diameter and 7 mm length (Maruho Hatsujo Kogyo, Kyoto) were coated with a gold layer of 50 nm thickness by ion sputtering (E-2380N; Hitachi, Ltd., Tokyo). The coils coated with gold were immersed in 1 mM 11-mercaptoundecanoic acid solution in ethanol for 24 hours at room temperature to form a self-assembled membrane on the coil surface. The coil was then immersed in 2% polyethyleneimine in distilled water followed by 2% heparin in distilled water to form heparin-coated coils. The heparincoated coils were sterilized by ethylene oxide gas treatment. Just before implantation, rhVEGF was immobilized on the heparin-coated coil by immersing in a 500 mg/ml rhVEGF solution to form VEGFimmobilized coils.
II. Preparation of rhVEGF
This experiment used rhVEGF 165 , one of four different molecular species of VEGF with 165 amino acids. VEGF was produced in the baculovirus expression system and purified at our institute as described previously. 9) Normal human umbilical vein endothelial cells (Cambrex Bio Science Walkersville, Inc., Walkersville, Md., U.S.A.) were used to assay the biological activity of the rhVEGF 165 
III. Infrared spectroscopy of VEGF immobilization
To prove the immobilization of rhVEGF on heparin-coated coils, infrared spectroscopy was performed. Slide glass plates (No.S-1111; Matsunami Glass Inc., Tokyo) were cleaned using piranha solution (concentrated sulfuric acid:30% hydrogen peroxide ＝ 7:3) for 5 minutes, and sequentially washed three times with Milli-Q water and 2-propanol (Nacalai Tesque, Kyoto), respectively. These glass plates were dried by blowing nitrogen gas and mounted on the rotation stage of a gold vapor deposition apparatus (V-KS200; Osaka Vacuum Instruments, Osaka). A chromium layer of 1 nm thickness followed by a gold layer of 199 nm thickness were deposited on the glass plates under 3.0 × 10
Pa at 30 rpm. The gold-coated glass plates were immediately immersed in 1 mmol/dm 3 11-mercaptoundecanoic acid (Aldrich, Milwaukee, Wis., U.S.A.) in ethanol (Nacalai Tesque). Formation of an alkanethiolate monolayer was allowed to proceed at room temperature for at least 24 hours. Finally the glass plates carrying the self-assembled monolayer were washed with water and 2-propanol, and then sequentially immersed in 2% polyethyleneimine solution and 2% heparin solution to immobilize cationic polyethyleneimine and anionic heparin on the glass plates. Finally, the heparinimmobilized plates were immersed in 87.5 mg/ml rhVEGF solution for 12 hours. rhVEGF was immobilized on the glass plates by interaction with the heparin.
Infrared absorption spectra of the surfaces were acquired by the reflection-absorption technique using a Spectrum One (PerkinElmer Inc., Wellesley, Mass., U.S.A.) equipped with a Reflector TM (Harrick Sci. Co., Ossining, N.Y., U.S.A.) and a liquid nitrogen-cooled mercury-cadmium telluride detector. The sample chamber was purged with a dry nitrogen gas, and a p-polarized beam with an incident angle of 75 degrees was used. All spectra were recorded at 4 cm 
IV. Rat aneurysm model and coil implantation
All animal experiments were conducted in accordance with policies set by the Animal Care and Use Committee of the Institute for Frontier Medical Sciences of Kyoto University. A total of 45 female 2-to 3-month-old Wistar rats (350-400 g) (Shimizu Jikken Zairyo, Kyoto) were divided into three groups. The anesthesia was induced with an in- VEGF-Immobilized Platinum Microcoils for Aneurysm Embolization traperitoneal injection of 60 mg/kg sodium pentobarbital. A midline skin incision was made in the anterior neck of the rat in the supine position. The superficial fascia and muscle layers were separated with blunt dissection until the right carotid sheath could be observed. Then the carotid bifurcation was thoroughly dissected. Temporary clips were applied to the common carotid artery (CCA) and internal carotid artery (ICA). A permanent ligature of the external carotid artery (ECA) was placed 7 mm distal to the origin of the ECA with 4-0 silk suture. After proximal control of the ECA had been obtained, with a complete cessation of arterial blood flow, a small arteriotomy was made at the ECA 2 mm proximal to the distal ligature.
A coil segment about 5 mm long was inserted into the ECA so the tip of the coil was located at the origin of the ECA. The platinum coil segments were unmodified, heparin-coated, and rhVEGF-immobilized coils (n ＝ 15 in each group). A new ligature with 4-0 silk suture was placed just at the arteriotomy with the coil to inhibit coil migration. The temporary clips of the CCA and ICA were then released to restore blood flow in the CCA and ICA. The operative field was inspected to confirm hemostasis and the location of the coil in the newly created sac in the ECA (Fig. 1) . Vasodilation and pulsation of the ECA sac were recognized upon removal of the temporary clips. The wound was closed with 4-0 nylon sutures, and the rats were replaced in their cages and given access to food and water ad libitum for the next 2 weeks.
V. Histological evaluation
The rats were sacrificed with an intraperitoneal injection of 300 mg/kg sodium pentobarbital 2 weeks after the operation. The previous incision was reopened, and the CCA, ICA, and ECA were exposed. The entire carotid bifurcation including the CCA, ICA, and ECA segments containing the coil was removed. Then, the inserted coil was removed from the ECA sac. The carotid bifurcation segments were fixed in 10% formalin for sectioning. Formalin-fixed segments were embedded in paraffin and sections of 5 mm thickness were prepared and stained with hematoxylin and eosin. Specimens with fibrotic material within the ECA sac were examined by immunohistochemical analysis using antibodies against rat Factor VIII (DAKO, Glostrup, Denmark).
The area of blood clots and newly formed connective tissue in the ECA sac was estimated using image analysis software (NIH Image; National Institutes of Health, Bethesda, Md., U.S.A.) and expressed as the percentage area of the blood vessel. The clot organization in the sac and endothelial formation at the orifice of the sac were semi-quantitatively scored by a pathologist unaware of the experimental group. Endothelial formation was graded as 0 for no formation, 1 for incomplete, and 2 for complete formation at the orifice of the ECA sac. Clot organization in the ECA sac was graded as 0 for no organization, 1 for less than 50% organization, 2 for more than 50% organization, and 3 for total organization expressed as the organization area to the ECA sac area.
Scanning electron microscopy was used for coil segments fixed in 2% glutaraldehyde at 49 C for 2 hours and then in 1% osmate at 49 C for 2 hours. Images were taken with a scanning electron microscope (S-2380N; Hitachi, Ltd.).
VI. Statistical analysis
The percentage of sac occlusion and the grades of endothelial formation and clot organization are given as the mean with standard deviation. Statistical analysis included a one-way analysis of variance using Fisher's probability of least significant difference for multiple post hoc group comparisons. Statistical results at p º 0.05 were considered significant. Fig. 2 Fourier transform infrared spectroscopy reflection-absorption spectra of the glass plates coated with heparin and recombinant human vascular endothelial growth factor (rhVEGF), respectively. The difference spectrum shows a peak assigned to amide I (arrow) at 1705 cm -1 . Fig. 3 Photomicrographs of the specimens of the carotid bifurcation segments 2 weeks after coil implantation. A: Unmodified group. No endothelial formation at the orifice of the external carotid artery (ECA) sac (endothelial formation score 0) (arrow) and no organization (organization score 0) (arrowhead) are seen. B: Heparin-coated group. Incomplete endothelial formation at the orifice of the ECA sac (endothelial formation score 1) (arrow) and less than 50% organization (organization score 1) (arrowhead) are seen. C: Recombinant human vascular endothelial growth factorimmobilized group. Complete endothelial formation at the orifice of the ECA sac (endothelial formation score 2) (arrow) and total organization in the ECA sac (organization score 3) (arrowhead) are seen. These slices are off lateral of the portion in which coils were previously inserted. Hematoxylin and eosin stain, original magnification ×40 (left), ×200 (right).
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T. Ohyama et al. Figure 2 shows the Fourier transform infrared spectroscopy reflection-absorption spectra of the glass plates with heparin coating and immobilized rhVEGF. The difference between these two spectra is also shown in Fig. 2 . The immobilization of rhVEGF on the gold surface is indicated by the peak at 1705 cm -1 assigned to amide I in the difference spectrum. rhVEGF is one of the polypeptides in which amino acids are linked by amino bonds. All amide bonds show RI absorption bands of a carbonyl known as the amide I and II bands in the region of 1700-1630 cm -1 and 1650-1515 cm -1 , respectively. Strong bands at these regions were observed in the Fourier transform infrared spectroscopy reflection-absorption spectra of the rhVEGF-immobilized surface as shown in Fig. 2 . This clearly indicates rhVEGF immobilization on the surface.
Results
I. Infrared spectroscopy of VEGF immobilization
II. Histological evaluation
Representative thin tissue sections from each group stained with hematoxylin and eosin are shown in Fig. 3 . Endothelial formation at the orifice was significantly greater for the rhVEGF-immobilized coils (1.50 ± 0.53) than for the heparin-coated coils (1.00 ± 0.00; p ＝ 0.014) or the unmodified coils (0.60 ± 0.52; p º 0.001). Clot organization was significantly greater for the rhVEGF-immobilized coils (2.20 ± 0.92) than for the heparin-coated coils Thin tissue sections of carotid bifurcation segments with a score of more than 1 for clot organization in the ECA sac were immunohistochemically stained for Factor VIII to assess the presence of endothelial cells (Fig. 4) . Factor VIII-positive sections in the organized tissue in the ECA sac were found in 0/15 for the unmodified coils, 4/15 for the heparin-coated coils, and 11/15 for the rhVEGFimmobilized coils.
Scanning electron microscopy of the coil segments removed from the ECA sac showed the rhVEGF-immobilized coils demonstrated more fibrotic and cellular collections on the coil surface compared to the unmodified and heparin-coated coils (Fig. 5) . The coil lumens contained a fibrotic and cellular solid mass (Fig. 6) . The tissue mass was solid in the lumen of the rhVEGF-immobilized coils, and filled about 40% of the inner lumen of the unmodified and heparin-coated coils.
Discussion
Surface modification of coils with polyurethanes and polyesters to increase the coil surface area can enhance thrombogenicity. 7, 16, 26) Surface coating with type I collagen resulted in better cellular response and better coverage with endothelial cells compared with unmodified coils. 7, 27) Coils conjugated with collagen threads induced local proliferation of fibroblasts and enhanced production of collagen within aneurysm cavities. 8, 26) Coils implanted with neon ions and coated with albumin, fibronectin, and collagen demonstrated improved cellular adhesion and proliferation. 21) Platinum coils carrying a reservoir of basic fibroblast growth factor displayed greater fibroblast proliferation than unmodified coils. 14, 15) Replacement of some platinum coils with biodegradable polyglycolyde fibers enhanced the inflammatory responses compared with only GDCs. 1) However, there are still various problems to be solved when using these modified coils. The connection between coating substances and platinum coil surfaces is usually weak and easily broken during the delivery of the coils, resulting in the risk of thrombus formation in distal vessels. Coil modification also may produce unfavorable changes affecting flexibility, thinness, smoothness, and memory shape. Otherwise, the biological activity of modified coils may not be adequate or the procedure to prepare the coils too complicated to use. In this study, the platinum microcoils were coated by the successive deposition of cationic polyethyleneimine and anionic heparin, followed by immobilization of VEGF through the affinity interaction with heparin. The interaction was confirmed by infrared spectroscopy of platinum-coated glass slides treated in the same way as the platinum GDCs used in the experiments.
This study used a rat aneurysm model at the ECA to compare the tissue reactions induced by rhVEGFimmobilized coils with those induced by unmodified platinum coils and heparin-coated coils. The ECA sacs treated with rhVEGF-immobilized coils showed significantly greater endothelial formation at the orifice of the ECA sac and connective tissue generation in the sac body than the ECA sacs treated with unmodified coils and heparin-coated coils. Immunochemical staining for Factor VIII confirmed the presence of endothelial cells within the organized clot of the aneurysm, suggesting that coils with rhVEGF can enhance the matrix formation needed to span the dome, and improve fibrosis.
New capillary vessels induced by VEGF may be involved in organizing the sac lumen and formation of the endothelial cell layer at the aneurysm orifice. Rapid endothelialization of vascular prostheses was induced by seeding autologous venous tissue fragments. 22) In the seeded graft, countless numbers of endothelial cells migrated from the fragments and emerged on the luminal surface, and smooth muscle cells formed multiple layers underneath the endothelial cell layer. This study suggests that endothelial cells can migrate from around the coil to the aneurysm orifice. Therefore, slow release of rhVEGF may be important in the formation of the endothelial cell layer at the aneurysm orifice.
The efficacy of rhVEGF-immobilized coils should be confirmed using a more realistic aneurysm model, such as vein pouch on a dog carotid artery, but the present results indicate the potential for use in endovascular detachable coil treatment.
VEGF-Immobilized Platinum Microcoils for Aneurysm Embolization to be improved. The efficient induction of thrombus formation inside the aneurysm after coil embolization is indispensable to improve the success rate of coil embolization. For this purpose, several techniques have been developed. The latest one is the hydocoil, which increases its volume after placement inside the aneurysm and effectively increases the obliteration ratio inside the aneurysm. 1) In this paper, another novel improvement of coils coated with the recombinant human VEGF (rhVEGF) is extensively investigated. The authors logically present the significant effectiveness of the rhVEGF coated coil compared with the non-coated coil. It is clearly revealed that this VEGF coated new coil can induce more efficient embolization of the aneurysm. The immobilization of this rhVEGF was also beautifully disclosed using infrared spectroscopy. This paper revealed that the clinical application of this type of coil is quite promising. However, the overproduction and induction of thrombosis may invoke another clinical problem, such as increase of the incidence of ischemic complication. In addition, it is well known that VEGF has some unfavorable adverse effects if given directly to the brain. However, it is quite conceivable that this enthusiastic and clinical oriented research will offer another possibility for safer and more consistent coil embolization. Consequently, it may widen the indications for endovascular treatment for cerebral aneurysms which are thought not to be suitable for coil embolization at present.
